Post-gemcitabine therapy for patients with advanced pancreatic cancer – A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimens-Reference-Cited by-同舟云学术

Post-gemcitabine therapy for patients with advanced pancreatic cancer – A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimens

Published:2016-11 Issue: Volume:50 Page:142-147
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Vogel Arndt,Ciardiello Fortunato,Hubner Richard A.,Blanc Jean-Frédéric,Carrato Alfredo,Yang Yoojung,Patel Dipen A.,Ektare Varun,de Jong Floris A.,Gill Sharlene

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference20 articles.

1. A systematic review of the burden of pancreatic cancer in Europe: real-world impact on survival, quality of life and costs;Carrato;J Gastrointest Cancer,2015

2. European cancer mortality predictions for the year 2016 with focus on leukaemias;Malvezzi;Ann Oncol,2016

3. Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303);Kindler;J Clin Oncol,2010

4. Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: southwest oncology group-directed intergroup trial S0205;Philip;J Clin Oncol,2010

5. Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer;Van Cutsem;J Clin Oncol,2009

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined chemotherapy based on bioactive black phosphorus for pancreatic cancer therapy;Journal of Controlled Release;2023-02

2. Efficacy and tolerability of the combination of nano-liposomal irinotecan and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma: post-approval clinic experience;Journal of Gastrointestinal Oncology;2021-04

3. Phase I/II trial of sequential treatment of nab-paclitaxel in combination with gemcitabine followed by modified FOLFOX chemotherapy in patients with untreated metastatic exocrine pancreatic cancer: Phase I results;European Journal of Cancer;2020-11

4. Chemotherapeutic efficacy of cucurmosin for pancreatic cancer as an alternative of gemcitabine: a comparative metabolomic study;Gland Surgery;2020-10

5. Real World Evidence on Second-Line Palliative Chemotherapy in Advanced Pancreatic Cancer;Frontiers in Oncology;2020-07-27